Results 91 to 100 of about 142,557 (303)

Nanotechnology and cell death: Revolutionizing disease treatment with nanoparticle strategies

VIEW, EarlyView.
Traditional disease treatments often face issues such as poor drug targeting and significant side effects, with many complex diseases lacking effective therapies. Our research utilizes tiny nanomaterials to treat diseases by regulating natural cell death processes, improving the immune environment, etc., enabling drugs to act more precisely.
Yiwen Wan, Wangzheqi Zhang, Yan Liao, Chenglong Zhu, Xiaojing Guo, Zui Zou, Mi Li   +6 more
wiley   +1 more source

Sodium Uptake in Peritoneal Dialysis [PDF]

, 1967
Miriam Moriarty
openalex   +3 more sources

Association of serum fetuin-A and biochemical parameters in hemodialysis patients. [PDF]

, 2014
Fetuin-A, a hepatic glycoprotein present in the circulation, is a potential inhibitor for systemic calcification. The main aim of this study was to evaluate the association between fetuin-A and other biochemical parameters as facilitator factors for ...
Besharat, S., Farajollahi, M., Haddad, M., Joshaghani, H.R., Qorbani, M., Tajbakhsh, R.   +5 more
core   +2 more sources

Efficiency comparison between new single‐needle dialysis and conventional double‐needle dialysis and exploration of the optimal prescription parameters for single‐needle hemodialysis

Therapeutic Apheresis and Dialysis, Volume 29, Issue 3, Page 419-427, June 2025.
Abstract Objective To compare the dialysis efficiency parameters between new single‐needle dialysis and conventional double‐needle dialysis and to explore the optimal prescription parameters for single‐needle hemodialysis. Methods This study involved a prospective, cross‐over design. Eight patients were randomly divided into two cohorts, which received
Bin Zhao, Shen Zhan, Gang Fu, Shanshan Guo, Lifang Liu, Wei Liu, Guanghui Xiao, Yuzhu Wang, Lihong Zhang   +8 more
wiley   +1 more source

Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease

BMC Nephrology
Background Diabetic kidney diseases (DKD) is a the most common cause of end-stage kidney disease (ESKD) around the world. Previous studies suggest that urinary podocyte stress biomarker, e.g.
Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto   +5 more
doaj   +1 more source

Effect of calcium dobesilate on peritoneal equilibration test in peritoneal dialysis patients

Linchuang shenzangbing zazhi
目的探讨羟苯磺酸钙对腹膜透析患者腹膜平衡实验（peritoneal equilibration test，PET）的影响。方法选择2023年6月1日至10月31日于中国医科大学附属第一医院肾内科住院的20例腹膜透析患者。20例腹膜透析患者口服羟苯磺酸钙前后检测腹膜平衡实验。结果口服羟苯磺酸钙以后，血肌酐显著降低［（1096.00 ± 220.00） μmol/L比（773.00 ± 257.00）μmol/L］、腹透液肌酐显著降低［（709.00 ± 196.00） μmol/L比（584.00 ...
Zhang Xue, Wu Wei, Gao Bo, Zheng Jian-nan, Yao Li, Zhu Xin-wang   +5 more
doaj   +1 more source

A case of ureteral myeloid sarcoma post-renal transplantation

BMC Nephrology, 2018
Background Significant attention has been directed toward the high incidence of malignant tumours that occur post-transplantation. However, there are few reports of myeloid sarcomas (MSs) following renal transplantation.
Liang Ying, Lei Tian, Yuanyuan Xie, Qin Wang, Xiajing Che, Jiayi Yan, Lijing Shen, Honghui Huang, Fangyuan Chen, Ming Zhang, Zhaohui Ni, Shan Mou   +11 more
doaj   +1 more source

Incremental peritoneal dialysis

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2020
Incremental peritoneal dialysis (PD) has been variably defined. It involves taking advantage of the residual renal function that is usually present at initiation of dialysis to initially prescribe less onerous lower doses of PD while still achieving individualized clearance goals.
Peter G. Blake, Jie Dong, Simon J. Davies   +2 more
openaire   +4 more sources

Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates

Therapeutic Apheresis and Dialysis, Volume 29, Issue 3, Page 471-478, June 2025.
Abstract Introduction Peritoneal solute transfer rates (PSTR) are reported to increase with time. Changes in PSTR were reviewed in long‐term peritoneal dialysis (PD) patients to determine whether lower glucose degradation products (low GDP) dialysates prevented an increase in PSTR. Methods PSTR was determined with a 4‐h peritoneal equilibrium test with
Andrew Davenport
wiley   +1 more source

Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL) : Study design and baseline data [PDF]

, 2018
Background: Intravenous (IV) iron supplementation is a standard maintenance treatment for hemodialysis (HD) patients, but the optimum dosing regimen is unknown.
Anker, Stefan D., Bhandari, Sunil, Farrington, Kenneth, Ford, Ian, Kalra, Philip A., Macdougall, Iain C., McMurray, John J.V., Murray, Heather, Steenkamp, Retha, Tomson, Charles R.V., Wheeler, David C., White, Claire, Winearls, Christopher G.   +12 more
core   +4 more sources